2018 - 2019 ISPE Board of Directors Installed

16 November, 2018

ISPE installed its 2018 – 2019 International Board of Directors at their 2018 ISPE Annual Meeting & Expo, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society.

The following pharmaceutical industry leaders have been elected to the 2018 – 2019 ISPE International Board of Directors:

Officers:

James Breen
Chair
Vice President, Global Engineering and Technology
Johnson & Johnson Innovative Medicines
Chair
Frances Zipp
Vice Chair
President/CEO
Lachman Consultant Services
Vice Chair
Tom Hartman
Treasurer
President & CEO
Treasurer
Joanne R. Barrick, RPh
Secretary
Sr. Director TS/MS Validation
Eli Lilly and Company
Secretary
Timothy P. Howard, PE
Past Chair
Executive Leadership Coach
Past Chair

Re-Elected Director:

Christine Moore
Executive Director, Quality Systems & Compliance
Organon LLC

New Directors:

Vivianne Arencibia
Vice President, Global Quality Systems and Compliance
Moderna
Gunter Baumgartner
SVP Head of Global Engineering
Takeda Pharmaceuticals International AG
Caroline Rocks
Senior Program Manager
AbbVie, Inc.

Appointed Director:

Chris Chen, PhD
CEO
WuXi Biologics (Shanghai) Co., Ltd.

Continuing Board Members:

In addition to those named above, the following Directors were elected in 2017 to serve a two-year term and will continue their service on the Board:

Antonio Crincoli
Vice President of Global Engineering
Catalent Pharma Solutions
Flemming Dahl
SVP Head of Product Supply Fill & Finish Expansions
Novo Nordisk A/S
Kelly M. Keen
Vice President, Head of PMO Project Management
Celonic Ag
Alice Redmond
Chief Strategy Officer
CAI
Michael Rutherford
Principal/ CEO/ Owner
Rutherford Consulting, LLC

Young Professionals Representative (Ex Officio):

LeAnna Pearson
Associate Director Quality Compliance and Regulatory
CAI

Learn more about ISPE’s International Board of Directors.